tirzepatide heart attack Mounjaro, Zepbound Lowers Risk of Cardiovascular Death by 62% Lower Risk of Cardiovascular Death

2010 Dec;81(12):658-62

This helps your body feel full longer and eat less, leading to steady weight loss

Brody AH, Nies SH, Guan F, Smith LM, Mukherjee B, Salazar SA, Lee S, Lam T, Strittmatter SM

As a class effect shared with GLP-1 receptor agonists, gallbladder problems including gallstones (cholelithiasis) and gallbladder inflammation (cholecystitis) have been observed with this type of medicine, and may be more likely with rapid weight loss

Among patients classified as high responders, those treated with the atezolizumab plus bevacizumab combination exhibited improved overall and progression-free survival as well as better objective response rate compared to those treated with sorafenib